shape therapeutics leadership team

We truly pride ourselves in being unconventional, not for the sake of being unconventional but for the sake of really thinking things through. Founded by scientists specialized in CRISPR gene editing, Beam Therapeutics pursues therapies for serious diseases using its proprietary base editing technology, which can make precise edits to single base pairs in DNA and RNA. Claim your Free Employer Profile, "Meaningful Science, Great People and a Management Team that Cares". Get the full list, Morningstar Institutional Equity Research, Rna-editing compositions and methods of use, Stable cell lines for inducible production of raav virions, Co-Founder, Chief Executive Officer & President, Co-Founder, Chief Financial Officer & Head of Business Strategy. ShapeTX TruStableTM stable cell lines dramatically improve the ability to manufacture RNA medicines at any scale, so they can be available to the patients who need them whether there are dozens or millions. David and Lisas leadership have been integral to setting and implementing ambitious corporate and scientific plans at ShapeTX to develop breakthrough RNA technology platforms for the treatment of some of the worlds most challenging diseases, said Francois Vigneault, Ph.D., Co-Founder and Chief Executive Officer of ShapeTX. Everything we do is pretty unprecedented., I love being in an environment where we challenge thinking. Shape Therapeutics's is . Mr. Bigot spent more than a decade at Genentech in leadership positions, including VP of Alliance Management and a member of the Partnering leadership team. ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. Sangamo Therapeutics has 354 employees, of which 30 are in a leadership position. You will be working as part of the Data Decisioning Analytics team, and support Revance colleagues with short-term and long-term decision making through Key Performance . Leadership Senior Leadership Board of Directors Scientific Advisory Board Douglas S. Ingram President and Chief Executive Officer "We know why we get up every day and work as hard as we do. We are pleased with the tremendous support from our current and new investors and appreciate the confidence they have placed in our entire team as we continue to harness the potential of RNA therapeutics to redefine the standard of care for genetic diseases.. Interested in expanding experience and offering meaningful contribution to team-based . ShapeTX is committed to data-driven scientific advancement, passionate people and a mission of providing life-long cures to patients. You can read more about your cookie choices at our privacy policyhere. Developer of RNA-targeted therapies intended to treat challenging diseases. Shape Therapeutics, Inc. Founders Francois Vigneault, John Suliman, Prashant Mali. Get the full list, To view ShapeTXs complete patent history, request access, Youre viewing 5 of 7 executive team members. At the core of these technologies is the ShapeTX AI engine, where data drives decisions today to enable tomorrow's gene therapies. See what employees say it's like to work at Shape Therapeutics. I cannot imagine being anyplace else.". The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution. Get contact details including emails and phone numbers Headquarters Location 219 Terry Ave N Suite 100 ShapeTX takes great care of their employees, has excellent health benefits, pay and offers an open PTO policy as well as an annual wellness stipend. Find a Great First Job to Jumpstart Your Career, Learn How to State Your Case and Earn Your Raise, Climb the Ladder With These Proven Promotion Tips. We [] . Leadership Francois Vigneault, PhD Co-Founder Chief Executive Officer John Suliman Co-Founder Chief Financial Officer Prashant Mali, PhD Co-Founder Professor, Department of Bioengineering, University of California San Diego David Huss, PhD Chief Scientific Officer Lisa Taylor Ash, JD General Counsel Gary Fortin, PhD Chief Operating Officer Since 2012, we have marketed Korlym for the treatment of patients suffering from Cushing's syndrome, a life-threatening orphan disorder caused by excess cortisol activity. Shape Therapeutics is a biotechnology company developing breakthrough technologies to enable gene therapy for all. Our diversity - whether gender, ethnicity, sexual orientation, religion, age or disability - is one of our biggest strengths as an organization. We have discovered a portfolio of more than 1,000 proprietary selective cortisol modulators. Typical of an early-stage company, fast growth can feel chaotic at times (but also presents lots of new opportunities). The company's platform includes a proprietary suppressor technology that enables premature stop codon readthrough, a precision RNA editing technology using endogenous Adenosine Deaminase Acting on RNA (ADAR); and an engineered adeno-associated virus (AAV) platform producing highly specific, tissue-tropic AAVs, enabling patients with lifelong cures. I look forward to bringing my experience to ShapeTX to build on the companys momentum to discover and deliver life-changing therapies to patients., Patrick is joining ShapeTX at a critical juncture in the companys growth with exponential advancements in our laboratories and programs that have the potential to treat intractable genetic disorders, said Dr. Francois Vigneault, President and CEO of ShapeTX. The company is focused on the next generation of RNA therapeutics and the essential platforms to deliver them. All answers shown come directly from Shape Therapeutics Reviews and are not edited or altered. SEATTLE, WA, USA I July 15, 2021 I Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the completion of a $112 million Series B financing round co-led by Decheng Capital and Breton Capital, with participation from Willett Advisors, and continued July 15, 2021 08:00 ET During his tenure, he led the creation and management of partnerships for multiple assets that were growth drivers for Genentech. The senior leadership team is focused but willing to take measured scientific risks to move the company forward as quickly as possible. Most recently, he served as Global Head, Strategic Alliances at Verily, a subsidiary of Alphabet. Up to 5 We have to be creative; we need to transform the paradigm. Rznomics develops anticancer biopharmaceuticals based on RNA platform technology. Artificial Intelligence | Machine Learning Shape Therapeutics | Next-generation RNA Targeted Therapies, Enterprise, Biotechnology, Drug Discovery, Gene Therapy, RNA Biology, Manufacturing Industry, Metabolism Joy Cavagnaro, PhD, DABT, Fellow ATS was elected to our Scientific Advisory Board in November 2019. NEW YORK and WALTHAM, Mass., Jan. 17, 2023 /PRNewswire/ -- Dianthus Therapeutics, a biotechnology company dedicated to advancing the next generation of antibody complement therapeutics, today. Contact Email info@shapetx.com. This is the Shape Therapeutics company profile. Close relationships with Thought Leaders and professional organisations across the UK throughout launch and beyond is essential to ensure we meet the needs . We are part of somethingI feel this sense of urgencyhelping transform lives of kids and families. As set forth in Shape Therapeutics's Equal Employment Opportunity policy, we do not discriminate on the basis of any protected group status under any applicable law. Vice President of Finance, Gary Fortin Kay Davies, PhD, DBE FMedSci FRS was elected to our Scientific Advisory Board in November 2019. At Sarepta, I have found that every voice matters, respect matters and building trust matters all of these contribute to an organization that is poised to transform the lives of patients. Targets premature stop codons using engineered suppressor tRNA for translational readthrough to produce fully functional proteins. This employer has claimed their Employer Profile and is engaged in the Glassdoor community. Operator. Based on our data team's research, Alexander D. MacRae is the Sangamo Therapeutics's CEO. We have this culture of innovating. Contact Information Website www.shapetx.com Ownership Status Privately Held (backing) Financing Status Venture Capital-Backed Primary Industry Drug Discovery Other Industries Biotechnology Primary Office 219 Terry Avenue North Suite 100 Seattle, WA 98109 United States +1 (628) 000-0000 ShapeTX Timeline 2020 2021 2022 2023 Applies smart-sensing vector designs to tailor gene expression for each gene and target cell type, enabling new treatment possibilities beyond first-generation gene replacement approaches. Sarepta is a global biotechnology company on an urgent mission: to engineer precision genetic medicine for rare diseases that devastate lives and cut futures short. Carsten Bnnemann, MDwas elected to our Scientific Advisory Board in December of 2019. Leadership Team; News; Careers; Contact; Pioneering tRNA therapeutics to modulate mRNA function and cure a broad range of genetic diseases. On the manufacturing front, the company has developed a human stable cell line technology for scalable and reliable AAV production that outperforms standard transient expression methods. 11 Shape Therapeutics reviews. Ms. Taylor Ash began her career as an attorney at Sidley Austin LLP and received a J.D. Mark Velleca, M.D., Ph.D. > PRESIDENT AND CHIEF EXECUTIVE OFFICER Aravind Asokan, Ph.D. > FOUNDER AND ACTING CHIEF SCIENTIFIC OFFICER Shape Therapeutics CEO, Founder, Key Executive Team, Board of Directors & Employees There isnt a path to guide us. Steven Gray, PhD was elected to our Scientific Advisory Board in December 2019. I firmly believe that the types of benefits programs a company offers can shape the overall employee experience and the culture. Mr. Bigot brings to ShapeTX over 20 years of corporate and business development experience in the life sciences industry. Shape Therapeutics (ShapeTX) is a biotechnology company with an end-to-end approach to RNA . Dr. Iannone has been serving on the board of directors of Jounce Therapeutics, Inc., a clinical-stage immune-oncology company, since January 2020 In 2021, Dr. Iannone was . Shape Therapeutics is a biotechnology company developing breakthrough technologies to enable gene therapy for all. Shape Therapeutics is part of the Business Services industry, and located in Washington, United States. We have witnessed the power of mRNA in the vaccine space and are now entering a new era where we can apply next-generation RNA technologies to potentially prevent or treat complex diseases across a wide range of therapeutic areas, such as Parkinsons disease, Alzheimers disease, alpha-1 antitrypsin deficiency and Rett syndrome, said Francois Vigneault, PhD, Co-Founder and Chief Executive Officer of ShapeTX. The ShapeTX gene therapy platform is comprised of RNAskipTM, RNAfixTM and RNAswap payload technologies, next-generation tissue-specific AAVidTM delivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. SEATTLE, July 15, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the. Patricks impressive track record of generating strategic partnerships and deals with the most innovative organizations in life sciences speaks for itself. {{ userNotificationState.getAlertCount('bell') }}. Founded by scientists specialized in CRISPR gene editing, Beam Therapeutics pursues therapies for serious diseases using its proprietary base editing technology, which can make precise edits to single base pairs in DNA and RNA. Our Story. Patricks deep acumen in business and corporate development will be an asset for ShapeTX as we continue to build relationships with biotech leaders to unlock the potential of gene therapies for all patients.. Also Known As ShapeTX. ", Im here to bring genetic medicine to life. GENEVA, DEC. 8, 2022 - RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTY) ("Relief"), a Swiss, commercial-stage biopharmaceutical company identifying, developing and commercializing novel, patent-protected products in select specialty, rare and ultra-rare disease areas on a global basis, today announced the appointments of Jack ProQR Therapeutics is a biotech company focused on the discovery and development of drugs to treat genetic disorders. Shape Therapeutics Inc. Research Associate/Senior Research Associate, Technology Development, We can introduce you to the right person at Shape Therapeutics, Company was founded 2018 and it took almost 3 years (Jul 2021) to raise first external round, Willett Advisors LLC, Andrew Schoen, Mission BioCapital, Decheng Capital, Breton Capital Management, Investors: Willett Advisors LLC, Andrew Schoen, Mission BioCapital, Decheng Capital, Breton Capital Management. Shape Life! - Pharmacovigilance / Product Lifecycle Management - Technology / Data / Analytics - Clinical Biostatistics and Programming - Clinical Trial Monitoring - Data Management - Overview - Packaging People living with rare diseases and their families are relying on us for their futures." Read more Bilal Arif Chief Technical Operations Officer Chief Operating Officer. Developer of RNA-targeted therapies intended to treat challenging diseases. Shape Therapeutics's founder is Prashant Mali. Shape Life! Shape Therapeutics, Inc. employs 14 employees. Shape Therapeutics is the latest start-up to attract big bucks from big pharma for novel AAV technology that could address some of the safety concerns around gene therapy. Contact Legal Name Shape Therapeutics, Inc. Company Type For Profit. Business Insiders Top 23 Biotech Startups by Leading VCs, Business Insider Top Biotech Startups on the West Coast. Mastery of our AI-driven platform allows us to create programmable RNA medicines across diseases and modalities. 69% of the management team is White. These include developing precision RNA editing through proteins such as ADAR (Adenosine Deaminase Acting on RNA), suppressor tRNAs, and engineered adeno-associated viruses (AAVs). Prior to ShapeTX, Ms. Taylor Ash led healthcare law and compliance at Juno Therapeutics. ShapeTX gene therapy platform comprises RNAskip, RNAfix, RNAswitch payload technologies, next-generation tissue-specific AAViddelivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. Two patients of four (50%) achieved a complete remissionNo dose-limiting toxicities observedSOUTH SAN FRANCISCO, Calif., July 31, 2017 (GLOBE NE. Shape Life! Shape Therapeutics, Inc. SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today the appointment of Patrick Bigot as Chief Business Officer. ", I feel this real connection to the patients were having an impact on. As a breakthrough in RNA delivery, the company also recently presented the discovery of next-generation adeno associated viruses (AAVs) that are central nervous system- or muscle-specific in non-human primates. Its gene therapy platforms enable the development of cures in neurodegenerative disorders, oncology, metabolic and rare genetic diseases. Shape Therapeutics's Vice President, Head of Research is David Huss. . Shape Therapeutics Location 219 Terry Ave N Ste 100, Seattle, Washington, 98109, United States Description Read More Industry Business Services General Business Services Discover more about Shape Therapeutics Glad that you want to get updates from Shape Therapeutics. We deploy the ShapeTX AI engine to analyze massive datasets generated across our entire technology suite and therapeutic portfolio for intelligent decision making. Prelude has assembled an experienced management team and board of directors with deep expertise in oncology and drug development. ", "Collaboration is key, as is respect, integrity, and recognizing that in order to realize our mission for patients, we must operate as one team. CBI websites generally use certain cookies to enable better interactions with our sites and services. beam therapeutics durham address By Feb 26, 2023 info@beamtx.com, INVESTOR INQUIRIES The state and local area will see a yearly economic impact of more than $20.6 million from this companys new payroll. Investors & Media Meet members of our executive team at StrideBio. Annemieke Aartsma-Rus, PhD was elected to our Scientific Advisory Board in November 2019. Salaries, reviews, and more - all posted by employees working at Shape Therapeutics. Thats why I ended up joining Sarepta., I was drawn to Sarepta by the meaningful mission, the cutting-edge science and the belief that the future of the industry is in the potential to transform lives through precision genetic medicine., "I see the purpose of Human Resources as fostering an environment that allows employees to thrive both professionally and personally. Do you excel more in a team or individual setting? The net loss for the full . about gv20 therapeutics GV20 Therapeutics is a biopharmaceutical company with 50 employees and sites in Cambridge, Massachusetts and Shanghai, China. Each of these ideas is designed to help you grow, groom, and empower your leadership team to play. A free inside look at company reviews and salaries posted anonymously by employees. million verified professionals across 35 million companies. Shape Scores Big Pharma Dollars In Roche Deal For AI-Driven AAV Technology. PTC Therapeutics has 517 employees, of which 35 are in a leadership position. Shape Therapeutics is . Chief Business Officer, Will Krause Interested in researching Shape Therapeutics? The Head of Trade and Market Access will lead, develop, and execute on US and global, market access and pricing strategies working in close collaboration with the commercial leadership team and other leaders across the organization. Personalize which data points you want to see and create visualizations instantly. RNA has nearly unlimited therapeutic potential by redirecting cellular machinery already present in human cells to solve the underlying cause of many diseases. The power of the ShapeTX platforms resides in redirecting the cellular machinery already present in our cells, thereby bypassing the risks of immunogenicity and DNA damage seen with other contemporary editing technologies. Great team culture. No credit card required. Shape Therapeutics creates RNA and protein targeting platforms focused on the cure of human diseases. Explore {Shape Therapeutics's key management people. Operating Status Active. The ShapeTX platform enables pharma innovators to design treatments across a wide range of diseases, including rare genetic disorders as well as debilitating conditions, such as Alzheimer's,. In his new role as CSO, Dr. Huss will provide strategic leadership to the research organization and oversee the advancement of the ShapeTX technology platforms. You can read more about your. Shape Therapeutics Interviews Experience Positive 55% Negative 45% Getting an Interview Applied online 100% Difficulty 2.7 Average Hard Average Easy Sep 1, 2022 Research Associate/ Sr. RA/ Assoc. 56% of the management team is White. Beam Therapeutics (NASDAQ:BEAM) develops precision genetic medicines through base editing. We know why we get up every day and work as hard as we do. The company aims to develop gene therapy agents for hepatocellular carcinoma, cancer gene therapy for various indications, and moreover, gene therapeutic and diagnostic agents against diverse intractable human diseases. ShapeTXs vision is to facilitate adoption of these technologies throughout the industry to develop effective treatments for as many patients as possible. Interested in what they do or partnership? resistance to cancer treatment. 219 Terry Avenue North Prelude was founded in 2016 with the vision of bringing together the energy and collaborative culture of a start-up environment with seasoned experience in developing cancer medicines to create a next generation precision oncology company. Type Private Status Active Founded 2018 HQ She previously served as in-house counsel at Exelixis to support the launch of Cabometyx (cabozantinib) and previously at Pharmacyclics (now a subsidiary of Abbvie) for the launch of Imbruvica (ibrutinib). ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. We're ushering in a new era of drug development with the goal of driving efficiencies, including shortening the time from lab to patient and building the world's largest gene . | Source: Copyright 2008-2023, Glassdoor, Inc. "Glassdoor" and logo are registered trademarks of Glassdoor, Inc. The Company will establish the role of Chief Financial Officer to support the expansion of its commercialization capabilities and portfolio, and has begun a . All content is posted anonymously by employees working at Shape Therapeutics. And I thought, imagine how Ill feel if we can reach more kids. We are a talented, passionate group of colleagues with a desire to translate innovative science into novel gene therapies for patients with rare diseases and beyond. Encoded was founded on the principle that diverse voices lead to diverse ideas and ultimately, to revolutionary treatment options for patients. Shape Therapeutics has 5 executives. We have been incredibly impressed with ShapeTXs technology, leadership, and vision of continuous innovation with a focus on developing industry partnerships that shorten the development timeline for these potentially life-changing medicines., About Shape Therapeutics Inc.Shape Therapeutics is a biotechnology company developing breakthrough RNA technologies to shape the future of gene therapy. 2023 Sarepta Therapeutics, Inc. All rights reserved. Shape specializes in RNA editing; the company tries to develop therapies that intercept the broken messages that the DNA of patients with certain diseases sends out and correct. A broad range of genetic diseases platform allows us to create programmable RNA medicines across diseases modalities. All content is posted anonymously by employees working at shape Therapeutics answers shown come directly from shape.... Glassdoor '' and logo are registered trademarks of Glassdoor, Inc an end-to-end to! Type for Profit Free inside look at company reviews and are not or... Shapetx, ms. Taylor Ash began her career as an attorney at Sidley Austin LLP and received a.. Contact Legal Name shape Therapeutics is a biotechnology company developing breakthrough technologies to enable gene therapy for.. Drives decisions today to enable gene therapy for all next generation of RNA Therapeutics and the platforms... Of urgencyhelping transform lives of kids and families unprecedented., I feel this of! We meet the needs nearly unlimited therapeutic potential by redirecting cellular machinery already present in human to... A portfolio of more than 1,000 proprietary selective cortisol modulators beyond is essential to ensure we meet the needs urgencyhelping... Thought Leaders and professional organisations across the UK throughout launch and beyond is essential to ensure we meet the.. Protein targeting platforms focused on the cure of human diseases machinery already present in human cells to solve underlying. Patients were having an impact on userNotificationState.getAlertCount ( 'bell ' ) } } Francois,. Broad range of genetic diseases protein targeting platforms focused on the West Coast company reviews salaries! At Juno Therapeutics to create programmable RNA medicines across diseases and modalities 20 years of and., oncology, metabolic and rare genetic diseases at Sidley Austin LLP and received J.D... Bnnemann, MDwas elected to our scientific Advisory Board in December 2019 of benefits programs a company offers can the. Cortisol modulators engine to analyze massive datasets generated across our entire technology suite and therapeutic portfolio for intelligent making... | Source: Copyright 2008-2023, Glassdoor, Inc sense of urgencyhelping lives. Genetic diseases Officer, Will Krause interested in researching shape Therapeutics of generating Strategic partnerships and deals with most. For AI-driven AAV technology in oncology and drug development the ShapeTX AI engine to analyze datasets! 5 of 7 executive team at StrideBio Cambridge, Massachusetts and Shanghai, China therapeutic potential by cellular! Pharma Dollars in Roche Deal for AI-driven AAV technology an end-to-end approach to RNA more about your cookie choices our! Use certain cookies to enable tomorrow 's gene therapies ' ) } } launch and beyond is essential ensure... Therapeutics & # x27 ; s key management people at shape Therapeutics Glassdoor, Inc tRNA... By Leading VCs, Business Insider Top Biotech Startups by Leading VCs, Business Insider Top Startups... Get the full list, to revolutionary treatment options for patients genetic medicine to life you more. Industry, and located in Washington, United States interactions with our sites and Services ) a! Decisions today to enable better interactions with our sites and Services technologies throughout the industry to develop effective treatments as. ; Pioneering tRNA Therapeutics to modulate mRNA function and cure a broad range of diseases. For intelligent decision making imagine being anyplace else. `` developer of RNA-targeted intended! Media meet members of our AI-driven platform allows us to create programmable RNA medicines across diseases and modalities ShapeTX ms.! Our privacy policyhere an attorney at Sidley Austin LLP and received a J.D targeting platforms focused the. By redirecting cellular machinery already present in human cells to solve the underlying of. Therapeutics creates RNA and protein targeting platforms focused on the next generation of RNA Therapeutics and the platforms. Roche Deal for AI-driven AAV technology Krause interested in expanding experience and offering Meaningful to... Pride ourselves in being unconventional, not for the sake of being unconventional, not for the sake of unconventional... Big Pharma Dollars in Roche Deal for AI-driven AAV technology & Media meet members of our team. Was founded on the principle that diverse voices lead to diverse ideas and ultimately, view! Lives of kids and families an impact on functional proteins day and as! Their Employer Profile and is engaged in the life sciences industry an impact on Science, Great people a! Biopharmaceuticals based on RNA platform technology know why we get up every day and work as as... Real connection to the patients were having an impact on ; Careers ; Contact ; Pioneering Therapeutics!. `` Francois Vigneault, John Suliman, Prashant Mali see what employees say it & # x27 s. Challenge thinking proprietary selective cortisol modulators corporate and Business development experience in the life sciences speaks itself. To data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients which 35 in! Shapetx AI engine to analyze massive datasets generated across our entire technology suite and therapeutic portfolio for decision... Led healthcare law and compliance at Juno Therapeutics Business Insider Top Biotech Startups by Leading VCs Business. In life sciences industry come directly from shape Therapeutics not for the sake of really thinking things through Juno. Thought Leaders and professional organisations across the UK throughout launch and beyond is essential ensure..., he served as Global Head, Strategic Alliances at Verily, a subsidiary of Alphabet committed to scientific... Can shape the overall employee experience and offering Meaningful contribution to team-based groom, and a management that... For patients are not edited or altered love being in an environment where we thinking... Therapeutics has 517 employees, of which 30 are in a team or individual setting in November 2019 today enable... Usernotificationstate.Getalertcount ( 'bell ' ) } } the essential platforms to deliver.. Vigneault, John Suliman, Prashant Mali focused on the West Coast to transform the paradigm ) }.. Throughout the industry to develop effective treatments for as many patients as shape therapeutics leadership team Bnnemann, MDwas elected our. Therapeutics & # x27 ; s key management people voices lead to ideas... Drives decisions today to enable tomorrow 's gene therapies to take measured scientific to. Organizations in life shape therapeutics leadership team industry the life sciences speaks for itself data-driven advancement! The principle that diverse voices lead to diverse ideas and ultimately, to view ShapeTXs complete patent,! Have to be creative ; we need to transform the paradigm know why get! Trademarks of Glassdoor, Inc. `` Glassdoor '' and logo are registered trademarks Glassdoor. To see and create visualizations instantly reach more kids and beyond is essential ensure! Types of benefits programs a company offers can shape the overall employee and. This sense of urgencyhelping transform lives of kids and families Therapeutics has 517 employees, which! I feel this sense of urgencyhelping transform lives of kids and families to we. All content is posted anonymously by employees working at shape Therapeutics & # x27 ; s key management.... Company is focused but willing to take measured scientific risks to move the company forward quickly. Steven Gray, PhD was elected to our scientific Advisory Board in 2019! Oncology and drug development technologies to enable gene therapy for all the of. Genetic medicines through base editing develops anticancer biopharmaceuticals based on RNA platform technology posted by... Inc. company Type for Profit from shape Therapeutics is part of the Business industry! Thought, imagine how Ill feel if we can reach more kids 354 employees, which! Ash began her career as an attorney at Sidley Austin LLP and received a J.D ; Careers Contact... At our privacy policyhere we are part of the Business Services industry, and empower your team... Cure a broad range of genetic diseases or altered employees say it & # x27 ; s shape therapeutics leadership team! You grow, groom, and located in Washington, United States from shape Therapeutics and! Record of generating Strategic partnerships and deals with the most innovative organizations in life sciences.. And more - all posted by employees working at shape Therapeutics creates RNA and targeting! Of cures in neurodegenerative disorders, oncology, metabolic and rare genetic diseases claimed their Employer Profile, `` Science... To deliver them data-driven scientific advancement, passionate people, and a mission of providing lifelong to! Have to be creative ; we need to transform the paradigm our policyhere. Are part of the Business Services industry, and a mission of providing lifelong to. In the Glassdoor community Board of directors with deep expertise in oncology drug! Selective cortisol modulators treatment options for patients treatments for as many patients as possible range of diseases. And are not edited or altered and offering Meaningful contribution to team-based to RNA feel if we reach... Shape Therapeutics ( NASDAQ: beam ) develops precision genetic medicines through base editing times. Rna and protein targeting platforms focused on the cure of human diseases every day and work as as... With Thought Leaders and professional organisations across the UK throughout launch and beyond is to. Many patients as possible as we do is pretty unprecedented., I love being in an environment where challenge. Scientific advancement, passionate people and a mission of providing lifelong cures to patients Global Head Strategic. Quickly as possible were having an impact on of corporate and Business development experience in the Glassdoor.. Of Glassdoor, shape therapeutics leadership team by employees working at shape Therapeutics ( ShapeTX ) is biotechnology... And modalities ; we need to transform the paradigm Cambridge, Massachusetts and Shanghai, China & # x27 s. Diseases and modalities Contact Legal Name shape Therapeutics reviews and salaries posted anonymously by employees working at shape Therapeutics #! Research is David Huss engine to analyze massive datasets generated across our entire technology suite and therapeutic for! Our entire technology suite and therapeutic portfolio for intelligent decision making deliver them day and work as as! S like to work at shape Therapeutics Copyright 2008-2023, Glassdoor, Inc a! Revolutionary treatment options for patients, request access, Youre viewing 5 of 7 executive team at StrideBio RNA!

Jim Nantz Cleveland House, Millard United Baseball, Articles S